US 11248044
Methods for altering body composition by administering a GDF8 inhibitor and an Activin A inhibitor
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11248044 (Methods for altering body composition by administering a GDF8 inhibitor and an Activin A inhibitor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/54, A61K2039/545